FDA requests additional data for TKTX Replagal BLA

Transkaryotic (TKTX) said the FDA requested additional data for its BLA for Replagal agalsidase alfa enzyme replacement therapy to treat Fabry disease. No further details were disclosed. Genzyme (GENZ...